Pembrolizumab (P) combined with chemotherapy (C) vs C alone as first-line (1L) therapy for advanced urothelial carcinoma (UC): KEYNOTE-361


Alva A., Csoszi T., Ozguroglu M. , Matsubara N., Geczi L., Cheng S. Y. , ...Daha Fazla

ESMO Virtual Congress, ELECTR NETWORK, 19 Eylül - 18 Ekim 2020, cilt.31 identifier